Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Service Corp International
SCI
$11.5B
| $5.57M | 0.01% |
263,270
-75,835
| -22% | -$1.62M |
|
|
ENZ
1227
DELISTED
Enzo Biochem, Inc.
ENZ
| $5.54M | 0.01% |
1,075,620
+49,944
| +5% | +$266K |
|
|
NSR
1228
DELISTED
Neustar Inc
NSR
| $5.53M | 0.01% |
222,856
+191,835
| +618% | +$5.29M |
|
1229
Tyler Technologies
TYL
$14.6B
| $5.53M | 0.01% |
+62,495
| New | +$5.64M |
|
1230
CALL
Prothena Corp
PRTA
$482M
| $5.49M | 0.01% |
313,100
+112,900
| +56% | +$2.39M |
|
1231
Western Union
WU
$2.28B
| $5.49M | 0.01% |
342,313
+320,335
| +1,458% | +$5.51M |
|
1232
Realty Income
O
$59.8B
| $5.49M | 0.01% |
138,776
+134,117
| +2,879% | +$5.72M |
|
1233
M/I Homes
MHO
$3.84B
| $5.47M | 0.01% |
276,113
-60,040
| -18% | -$1.31M |
|
1234
Silicon Motion
SIMO
$8.25B
| $5.47M | 0.01% |
203,151
-153,485
| -43% | -$3.86M |
|
|
HAWK
1235
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $5.47M | 0.01% |
169,208
+39,243
| +30% | +$1.11M |
|
|
OPLN
1236
Openlane
OPLN
$4.16B
| $5.47M | 0.01% |
504,717
-494,110
| -49% | -$5.65M |
|
1237
Cheniere Energy
CQP
$32.9B
| $5.46M | 0.01% |
166,800
-81,700
| -33% | -$2.67M |
|
|
VIVO
1238
DELISTED
Meridian Bioscience Inc
VIVO
| $5.46M | 0.01% |
308,366
+191,640
| +164% | +$3.77M |
|
|
KMR
1239
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
| $5.46M | 0.01% |
+58,805
| New | +$5.07M |
|
1240
PUT
Yum! Brands
YUM
$42.9B
| $5.44M | 0.01% |
105,160
-20,030
| -16% | -$1.07M |
|
1241
Baxter International
BAX
$13.7B
| $5.44M | 0.01% |
139,435
-1,531,436
| -92% | -$62.2M |
|
|
SIVB
1242
DELISTED
SVB Financial Group
SIVB
| $5.44M | 0.01% |
48,497
+20,183
| +71% | +$2.24M |
|
1243
PUT
Bristol-Myers Squibb
BMY
$137B
| $5.42M | 0.01% |
106,000
+5,300
| +5% | +$265K |
|
|
CAJ
1244
DELISTED
Canon, Inc.
CAJ
| $5.42M | 0.01% |
+166,470
| New | +$5.5M |
|
|
NTT
1245
DELISTED
Nippon Telegraph & Telephone
NTT
| $5.42M | 0.01% |
174,150
+160,055
| +1,136% | +$5.24M |
|
1246
Phillips 66
PSX
$96.5B
| $5.41M | 0.01% |
66,542
-410,039
| -86% | -$34.1M |
|
1247
CALL
Teva Pharmaceuticals
TEVA
$43B
| $5.38M | 0.01% |
100,000
| – | – |
|
1248
Nu Skin
NUS
$232M
| $5.37M | 0.01% |
119,303
+31,281
| +36% | +$1.66M |
|
|
XENT
1249
DELISTED
Intersect ENT, Inc
XENT
| $5.36M | 0.01% |
+346,041
| New | +$5.21M |
|
1250
Digital Turbine
APPS
$1.3B
| $5.36M | 0.01% |
1,170,000
-90,037
| -7% | -$400K |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.